Open original FDA record ↗Recall record
- FDA identifier
- Z-2364-2023
- Company in FDA record
- Scholly Fiberoptic Gmbh
- FDA classification date
- Aug 9, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is an improperly performed weld between the cone of the sheath lock and tube of the obturator; mechanical load capacity is impaired, and fracture of the welded joint may occur. Contamination can occur in this capillary gap, which is not covered by the reprocessing validations performed.
Source facts
- Action
- SCHOLLY FIBEROPTIC GMBH initiated Recall Plan Letter to Users, Importers and Distributors . The US Distributor- Teleflex (parent company of NeoTract) notified on June 23, 2023 to forward the notification letter to their customers. Letter states reason for recall, health risk and action to take: Review this Field Safety Notice in its entirety and ensure that all users of the above-mentioned product in your organization and other concerned persons are informed about this Field Safety Notice. 2. If you are a distributor, please forward this correction notification to your customers. 3. Identify, quarantine and return affected devices. 4. Do not use affected devices anymore. 5. Exchange devices from the above-mentioned batches, which are currently in use. 6. Confirm receipt of this information by filling in the attached reply form and returning it to the indicated e-mail address. E-Mail: vigilance@schoelly.de
- Initiated
- 2023-06-23
- Root cause
- Process control
- Distribution
- Nationwide Foreign: Japan, South Korea
- Recall number
- Z-2364-2023
- Recall status
- Open, Classified
- CDRH record ID
- 202206
- FDA classified
- 2023-08-09
- Recall event number
- 92700